Skip to main content

Table 2 Clinical characteristics of patients with high or low VDJ%

From: In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival

  High VDJ% High VDJ% Low VDJ% Low VDJ% High VDJ% Low VDJ% Remission Samples
   Unt/Ch RR/Ch Unt/Ch RR/Ch ASCT ASCT  
Age ≥65 11/16 12/24 20/24 13/25 5/29 6/21 11/33
Albumin >30 13/15 23/24 20/24 24/24 26/27 19/21 27/28
β2M ≥3 12/14 16/21 16/19 14/22 18/24 9/18 18/26
Calcium ≥2.5 1/14 8/23 5/24 5/24 7/26 6/21 11/29
Creatinine ≥177 3/14 5/24 6/24 0/24 7/28 1/21 4/29
Hemoglobin >100 8/16 13/24 18/24 20/24 15/29 14/20 23/30
LDH >618 6/14 2/24 2/22 2/23 6/25 1/21 3/28
t(4;14) Positive 0/12 3/15 3/18 2/19 2/20 2/15 5/29
Stage III 7/14 10/21 9/19 8/22 8/23 5/18 10/25
  1. Unt=Untreated, RR = relapse/refractory, Ch = only conventional chemotherapy.